Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Lustig

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Nature Communications|May 13, 2026
Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot studyHamed Akbari, Suyash Mohan, Fang Liu, et al.
Scientific Data|July 29, 2022
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomicsSpyridon Bakas, Chiharu Sako, Hamed Akbari, et al.
Nature Cancer|January 12, 2024
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trialStephen J Bagley, Zev A Binder, Lamia Lamrani, et al.
Neuro-Oncology|December 12, 2024
Machine learning-based prognostic subgrouping of glioblastoma: A multicenter studyHamed Akbari, Spyridon Bakas, Chiharu Sako, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Nature Communications|May 13, 2026
Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot studyHamed Akbari, Suyash Mohan, Fang Liu, et al.
Scientific Data|July 29, 2022
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomicsSpyridon Bakas, Chiharu Sako, Hamed Akbari, et al.
Nature Cancer|January 12, 2024
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trialStephen J Bagley, Zev A Binder, Lamia Lamrani, et al.
Neuro-Oncology|December 12, 2024
Machine learning-based prognostic subgrouping of glioblastoma: A multicenter studyHamed Akbari, Spyridon Bakas, Chiharu Sako, et al.
Pageof 6